Theravance Information

Theravance Biopharma, Inc. ("Theravance Biopharma") is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. The company was founded in 2013 and is headquartered in South San Francisco, California.

Website	http://www.theravance.com
Ticker	TBPH
Revenue	$62 million
Funding	$1.3 billion
Employees	18 (0 on RocketReach)
Founded	1996
Address	901 Gateway Blvd, South San Francisco, California 94080, US
Phone	+1 650-808-6000
Technologies	JavaScript , HTML , PHP +68 more (view full list)
Industry	Pharmaceuticals, Biopharma, Healthcare, Biotechnology, Health Care, Science and Engineering, Medical, Pharmaceutical
Web Rank	4 Million
Keywords	Pharmaceutical Development, Pharmaceutical Innovation, Therapeutic Development, Drug Discovery, Medicine Commercialization, Drug Research, Biopharmaceutical Research, Clinical Trials, Biotechnology, Innovative Therapies, Pharmaceutical Products, Therapeutic Agents, Prescription Drugs, Medical Innovation, Drug Manufacturing
Competitors	Johnson & Johnson, Roche, Novartis, AbbVie, Merck & Co., Inc., Pfizer, GSK, Amgen, Boehringer Ingelheim, Lilly India +45 more (view full list)
SIC	SIC Code 283 Companies, SIC Code 28 Companies
NAICS	NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies